EVAg

Reverse genetics system to generate infectious Ebola virus Mayinga strain

Reverse genetics system to generate infectious Reston virus 1989 US strain

Plasmid coding the full-length antigenome of Ebola virus isolate Makona from West African outbreak 2014. The plasmid can be used for the rescue of recombinat virus.

Plasmid coding the full-length antigenome of Ebola virus Zaire isolate Mayinga (AF086833) . The plasmid can be used for the rescue of recombinat virus.

Plasmid encoding the full-length anti-genome of Marburg virus strain Musoke under the control of the T7 polymerase for rescue experiments. The plasmid contains two genetic markers: insertion of a SacII restriction site in the GP gene (nt position 10511a to g silent mutation) and a silent mutation at nt position 9485 c toT in the GP gene resulting in the deletion of a KpnI restriction site

EBOV G antiserum (Rabbit 426)

EBOV G antiserum (Rabbit 437)

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 12x8 rxns) for real time PCR of Sudan virus (Ebolavirus) SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase. For RUO (research use only). Extracted RNA of Sudan ebolavirus Gulu can be found here : Ref-SKU: 002N-04805 https://www.european-virus-archive.com/nucleic-acid/sudan-ebolavirus-strain-gulu-rna

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 4x24 rxns) for real time RT-PCR of Marburg virus SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase. For RUO (research use only).

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 12x8 rxns) for real time PCR of Ebolavirus Zaïre SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase. For RUO (research use only).

rekombinant MARV expressing eGFP generated from full-length plasmid

infectious cell culture supernatant containing recombinant Ebola virus based on DOI: 10.1086/520590

RNA extracted from cell culture supernatant

Reverse genetics-based life cycle modelling system that allows modelling of Ebola virus genome replication and transcription, viral protein synthesis, virus assembly, budding, and Lloviu virus entry into target cells under BSL1 conditions.

Reverse genetics-based life cycle modelling system that can serve as negative control and is best used together with other trVLP systems that allows modelling of Ebola virus genome replication and transcription, viral protein synthesis, virus assembly, budding, and entry into target cells under BSL1 conditions.

Infectious cell culture supernatant containing Zaire ebolavirus. The virus is preserved in Viral Storage Medium at -150°C. Tests for the presence of mycoplasmae were negative.

RNA extracted from cell culture supernatant. Stored in buffer AVE (QIAGEN).

RNA of Zaire ebolavirus isolate Ebola virus H.sapiens-tc/GIN/2014/Makona-C05 extracted from cell culture supernatant

RNA of Zaire ebolavirus isolate Ebola virus H.sapiens-tc/GIN/2014/Makona-Gueckedou-C07 extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA of Zaire ebolavirus isolate Ebola virus H.sapiens-tc/GIN/2014/Makona-Kissidougou-C15 extracted from cell culture supernatant

Infectious cell culture supernatant. This Marburgvirus[Popp] is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative.

Infectious cell culture supernatant. This Zaire ebolavirus[Gabon 2003] is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative.

. This Sudan ebolavirus[Gulu] is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were positive. To confirm its identity the virus has been partly sequenced.